Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.45%Cost of Revenue Margin
VS
Market
Sector
Industry
History
$ 1.77Close
$ 0.39 - $ 1.79 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - Cost of Revenue Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - COGS % Historical data
| Date | Cost of Revenue | Cost of Revenue Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 267K | 2.45% | $ 10.91M |
| 3/31/2025 | $ 272K | 2.85% | $ 9.56M |
| 12/31/2024 | $ 334K | 3.52% | $ 9.5M |
| 9/30/2024 | $ 436K | 5% | $ 8.72M |
| 6/30/2024 | $ 567K | 9.17% | $ 6.19M |
| 3/31/2024 | $ 650K | 8.12% | $ 8M |
| 12/31/2023 | $ 671K | 7.5% | $ 8.95M |
| 9/30/2023 | $ 517K | 5.89% | $ 8.77M |
| 6/30/2023 | $ 583K | 5.54% | $ 10.52M |
| 3/31/2023 | $ 671K | 5.66% | $ 11.85M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) COGS % stands at 14.53%.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average COGS % has been 12.48%.
- The median COGS % for LINEAGE CELL THERAPEUTICS INC during this period was 7.81%
- LINEAGE CELL THERAPEUTICS INC reached its highest COGS % over the past 5 years at 37.87%.
- The lowest COGS % recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe 2.45%
LINEAGE CELL THERAPEUTICS INC's COGS % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS % Benchmarks
Similar metrics to Revenues:
- Cost of Revenue - [Income Statement] The cost of revenue is the total amount paid to produce and sell a product or service and can be found in the income statement.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
Definition of Cost of Revenue Margin
[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.COGS / Revenues
(=) COGS % COGS % for LINEAGE CELL THERAPEUTICS INC is calculated as follows: COGS [ $ 394K ] / Revenues [ $ 2.71M ]
(=) COGS % [ 14.53% ] LCTX - Cost of Revenue Margin, Last 5 years
2.45%
Minimum
Jun 30, 2025
37.87%
Maximum
Sep 30, 2021
12.48%
Average
7.81%
Median
COGS % Benchmark AnalysisMarket
The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.87% with a standard deviation of 31.57%.
The following table provides additional summary stats:
COGS % in the Market:
| filtered constituents | 3.8K |
|---|---|
| min | -50.26% |
| max | 172.25% |
| average | 46.87% |
| median | 50.52% |
| std | 31.57% |